- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-09-0004230

Flaxelle Medicare Private Limited
About Flaxelle Medicare Private Limited
Data last updated:
Flaxelle Medicare Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 06 February 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2020PTC361491.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Savita Singh and Chandra Bhan Singh.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at F – 90/26 Okhla Industrial Area Phase – 1, New Delhi, Delhi, India – 110020.
As per the financials filed for FY 2023, the company reported a revenue of ₹18.04 Lakh, a decline of 3% compared to the previous year. For the same year it recorded a net loss of ₹5.05 Lakh (net margin -28%) and EBITDA of -₹3.25 Lakh (EBITDA margin -18%).
The company has about 2 employees on its provident fund (EPFO) records.
Flaxelle Medicare Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-09-0004230).
Company details
Recognitions & Rankings of Flaxelle Medicare
Contact details
Flaxelle Medicare Private Limited's registered office is in New Delhi, Delhi.
- Registered AddressF – 90/26 Okhla Industrial Area Phase – 1, New Delhi, Delhi, India – 110020
- IndustryChemicals, Manufacturing, Basic Chemical
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Flaxelle Medicare is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Flaxelle Medicare Private Limited, buy the company report.
Financials of Flaxelle Medicare Private Limited
FY 2023 filings availableFlaxelle Medicare Private Limited reported revenue of ₹18.04 Lakh (down 3% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue fell 3% in the latest year. EBITDA rose 84% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹3.25 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹5.05 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -18% | |||
| Net Profit Margin | -28% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Flaxelle Medicare Private Limited, buy the company report.
Board of directors of Flaxelle Medicare Private Limited
Flaxelle Medicare has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chandra Bhan Singh | Additional Director | 14 Oct 2020 | 6 Years 1 Months | Current |
| Savita Singh Also directs: 7Series Buildwell Private Limited | Director | 06 Feb 2020 | 6 Years 9 Months | Current |
Peer comparison
Flaxelle Medicare Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Always Dry India Private Limited | ₹18.08 Lakh (FY 2025) | 4.0% | Delhi, India | |||
| Sphere Bio-Arc Private Limited | ₹18.08 Lakh (FY 2022) | -96.0% | Savli, Gujarat, India | |||
| Aryed Private Limited | ₹18.07 Lakh (FY 2023) | Delhi, India | ||||
| Sapal Limited | ₹18.07 Lakh (FY 2024) | -83.0% | Nashik, Maharashtra, India | |||
| Prunus Lifesciences India Private Limited | ₹18.07 Lakh (FY 2022) | 36.0% | Bangalore, Karnataka, India | |||
| Flaxelle Medicare Private Limitedthis company | ₹18.04 Lakh (FY 2023) | -₹5.05 Lakh | -28% | -3.0% | New Delhi, Delhi, India | |
| Anupam Coatings Private Limited | ₹18.04 Lakh (FY 2024) | 100.0% | Kolkata, West Bengal, India | |||
| Dia Herbal Healths Pharmaceuticals Private Limited | ₹18.02 Lakh (FY 2024) | 140.0% | Kottayam, Kerala, India | |||
| Enkay Organics Private Limited | ₹18 Lakh (FY 2025) | 80.0% | Mumbai, Maharashtra, India | |||
| Beta Organic Chemical Industries Pvt Ltd | ₹17.99 Lakh (FY 2025) | -36.0% | Maroli Bazar, Gujarat, India | |||
| Shivansh Pharmatecals Private Limited | ₹17.95 Lakh (FY 2017) | -28.0% | Moradabad, Uttar Pradesh, India |
To see the full peer comparison of Flaxelle Medicare Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Flaxelle Medicare Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Flaxelle Medicare Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Flaxelle Medicare Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Flaxelle Medicare Private Limited has 4 board changes on record since 2020: 2 appointments and 2 cessations. The latest: Pravesh Kumar Singh ceased to be Director on 19 Aug 2021.
Frequently asked questions
Flaxelle Medicare is an active private limited company based in New Delhi, Delhi, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 06 February 2020 (6+ years old) and is registered under CIN U24100DL2020PTC361491.
Flaxelle Medicare has 2 current directors:
- Chandra Bhan Singh - Additional Director
- Savita Singh - Director
The latest financial statements of Flaxelle Medicare on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of Flaxelle Medicare is U24100DL2020PTC361491. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Flaxelle Medicare was incorporated on 06 February 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Flaxelle Medicare by revenue are Always Dry India Private Limited, Sphere Bio-Arc Private Limited, Aryed Private Limited, Sapal Limited, Prunus Lifesciences India Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Pravesh Kumar Singh ceased to be Director on 19 Aug 2021. Chandra Bhan Singh was appointed as Additional Director on 14 Oct 2020. Syad Zaidi Mohamamd Yasir ceased to be Director on 23 Sep 2020. Flaxelle Medicare has 4 board changes on record in total.
Yes, Flaxelle Medicare is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-09-0004230).
The registered office of Flaxelle Medicare is at F – 9026 Okhla Industrial Area Phase – 1, New Delhi, Delhi, India – 110020.
Flaxelle Medicare operates in the chemicals industry, in the manufacturing segment.
Flaxelle Medicare can be reached at its registered office: F – 9026 Okhla Industrial Area Phase – 1, New Delhi, Delhi, India – 110020.

